|
|
News Breaks | | | | November 15, 2012 | | 09:58 EDT |  | SPEX | Spherix, Fullife Healthcare sign supply and license agreement
Spherix Incorporated and Fullife Healthcare announced the signing of a supply and license agreement for the use of D-tagatose in nutraceutical products in India. Under the terms of the agreement, Spherix has granted Fullife an exclusive, royalty-bearing license in India for use of Spherix's clinical data and proprietary know-how to support marketing and dosing of the D-tagatose that Spherix will also be supplying. The D-tagatose will be used in food or cosmetic products that may provide health benefits in return for a fixed royalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife and Fullife will be responsible for all testing and development of products containing D-Tagatose for sale in India. Financial terms of the agreement were not disclosed. | |
|
News For SPEX From The Last 14 Days Check below for free stories on SPEX the last two weeks. |
|
|
| There are no results for SPEX |
|
|
|
|
|
|
